{"id":"W2096198028","doi":"10.1177/1756287215589250","title":"The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results of a noninferiority, randomized, phase IIIb trial","year":2015,"lang":"en","type":"article","venue":"Therapeutic Advances in Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Solifenacin; Mirabegron; Overactive bladder; Medicine; Urology; Clinical endpoint; Nocturia; Randomized controlled trial; Population; Internal medicine; Tolerability; Confidence interval; Adverse effect; Urinary system","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003767223,0.001364027,0.002834967,0.000400431,0.0004236533,0.0009551015,0.0009364113,0.001712554,0.003886673],"category_scores_gemma":[0.003418288,0.0008026968,0.002588698,0.0003851303,0.00132552,0.0008443462,0.0004367251,0.002598291,0.000551926],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007568871,"about_ca_system_score_gemma":0.001187064,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006082414,"about_ca_topic_score_gemma":0.001449529,"domain_scores_codex":[0.9983265,0.001122654,0.0001324581,0.0001726895,0.0001351765,0.0001104725],"domain_scores_gemma":[0.9970589,0.00114222,0.0009636845,0.0001675997,0.0001450359,0.0005225923],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9810503,0.005662725,0.001327082,0.0003893848,0.001056352,0.0000190879,0.00003778766,0.000171338,0.002417302,0.00002494503,0.0001523669,0.007691521],"study_design_scores_gemma":[0.8705978,0.1242468,0.003380936,0.00002374907,0.0006754657,0.00002914127,0.00001630064,0.0002953227,0.0005232691,0.00003301043,0.0001675003,0.00001068498],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948671,0.002637566,0.0002733562,0.000301311,0.0001425542,0.001046909,0.0003028788,0.00002378701,0.0004045837],"genre_scores_gemma":[0.9943058,0.001553641,0.0009563958,0.0005325848,0.0003364226,0.001246333,0.0004730811,0.00001067285,0.0005850336],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003886673,"threshold_uncertainty_score":0.01992321,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05164584700548972,"score_gpt":0.3903095818201252,"score_spread":0.3386637348146354,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}